WeightWatchers, now WW International, filed for Chapter 11 bankruptcy to restructure $1.15 billion in debt, citing competition from weight-loss drugs like Ozempic. The iconic brand aims to relaunch holistically, ensuring uninterrupted services during reorganisation.
On May 7, 2025, WW International announced its Chapter 11 bankruptcy filing in New York to address $1.15 billion in debt, driven by the rise of weight-loss drugs like Ozempic and Wegovy, as reported by Bloomberg.
WeightWatchers is preparing to file a prepackaged bankruptcy "imminently" in order to execute a debt restructuring plan supported by its lenders https://t.co/AWmnPjWZHB
— Bloomberg (@business) May 6, 2025CEO Tara Comonte emphasised a commitment to “science-backed, holistic solutions,” stating, “These actions will accelerate innovation and reinvest in our members,” per Reuters. The company expects to emerge as a publicly traded entity within 40 days, with services continuing seamlessly, per CNBC.
The filing follows challenges intensified by Oprah Winfrey’s 2024 board exit after disclosing her use of anti-obesity medication, per Forbes. WW’s 2023 acquisition of Sequence to enter the telehealth medication market aimed to adapt. However, declining demand for traditional diet programs persists, with Novo Nordisk’s stock rising 6% after an FDA crackdown on Ozempic copycats, per The Wall Street Journal.
#BREAKINGNEWS: WeightWatchers, the 62-year-old program that revolutionized dieting for millions of people around the world, has filed for bankruptcy.
The company has struggled with about $1.5 billion in debt and has failed to keep pace with more convenient weight loss options,… pic.twitter.com/zosBZVZxsY
— ABC7 Eyewitness News (@ABC7) May 6, 2025Founded in 1963 by Jean Nidetch, Weight Watchers pioneered weight loss through calorie counting and support groups. However, the pharmaceutical shift, with drugs like Wegovy transforming the industry, has eroded its market, as noted on X. WW’s restructuring seeks to pivot toward integrated health solutions, aligning with evolving consumer needs, per Business Insider.
WeightWatchers’ Chapter 11 filing on May 7, 2025, to restructure $1.15 billion in debt is pivotal as it battles competition from drugs like Ozempic. With a 40-day plan to relaunch as a holistic health brand, WW aims to reclaim relevance. The iconic company’s reinvention will shape its six-decade legacy in a rapidly changing industry.
